Learn More
Medchemexpress LLC Nampt-IN-3 | 2121591-52-2 | 99.0% | 503.55 | 100 MG

Supplier: Medchemexpress LLC HY10870150MG
Nampt-IN-3 (Compound 35) simultaneously inhibits nicotinamide phosphoribosyltransferase (NAMPT) and HDAC with IC50s of 31 nM and 55 nM, respectively. It effectively induces cell apoptosis and autophagy, leading to cell death.
- Inhibits nicotinamide phosphoribosyltransferase (NAMPT) and HDAC with IC50s of 31 nM and 55 nM.
- Effectively induces cell apoptosis and autophagy.
- Leads to cell death.
- Demonstrates cytotoxicity in human HCT116 cells with an IC50 of 2.4 μM.
- Demonstrates cytotoxicity in human HepG2 cells with an IC50 of 4.5 μM.
- Demonstrates cytotoxicity in human MDA-MB-231 cells with an IC50 of 10 μM.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.